Oman Celiac Disease Treatment Market Report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Oman Celiac Disease Treatment Market Overview

• The Oman Celiac Disease Treatment Market is valued at USD 42 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of celiac disease and gluten intolerance, heightened consumer awareness, and expanding demand for gluten-free products. The healthcare sector’s investment in advanced diagnostic capabilities, the expansion of specialty clinics, and the proliferation of online pharmacies have further contributed to market expansion. The influence of Western dietary habits and the rising trend toward health and wellness among urban populations are also key growth drivers .
• Muscat, Salalah, and Sohar remain the dominant cities in the Oman Celiac Disease Treatment Market. Muscat, as the capital, offers the highest concentration of healthcare facilities and specialized clinics, while Salalah and Sohar benefit from growing awareness and improved access to gluten-free products. The urban population in these cities is increasingly health-conscious, which further drives market growth through higher adoption of specialty diets and preventive healthcare practices .
• In 2023, the Omani government enacted the "Food Safety Regulation for Gluten-Free Products, 2023" issued by the Ministry of Agriculture, Fisheries and Water Resources. This regulation mandates that all food products labeled as gluten-free must comply with Codex Alimentarius standards, undergo laboratory testing to verify gluten content below 20 ppm, and display clear labeling. The regulation aims to protect consumers with celiac disease and ensure the safety and authenticity of gluten-free products in the market, thereby enhancing consumer confidence and market credibility .

Oman Celiac Disease Treatment Market Segmentation

By Type:The market is segmented into gluten-free foods, nutritional supplements, diagnostic tests, therapeutic products, and others. Gluten-free foods are the most prominent segment, driven by rising consumer demand for safe dietary options and the growing availability of specialty gluten-free products across retail and online channels. Nutritional supplements play a significant role in managing micronutrient deficiencies commonly associated with celiac disease, such as iron, calcium, and vitamin D. Diagnostic tests, including serological and genetic testing, are increasingly adopted due to improved awareness and healthcare infrastructure. Therapeutic products, such as enzyme therapies and immunomodulators, are emerging but remain a smaller segment. Supportive care products and patient education materials are also gaining importance as part of holistic disease management .

By End-User:The end-user segmentation includes hospitals, clinics, home care settings, pharmacies, and others. Hospitals, both public and private, dominate this segment due to their comprehensive treatment facilities, multidisciplinary teams, and access to advanced diagnostics for celiac disease patients. Specialty clinics focused on gastroenterology and nutrition are also significant, particularly in urban centers. Home care settings are gaining traction for ongoing dietary management, while pharmacies—especially those with dedicated gluten-free product sections—play a growing role in product distribution. Diagnostic labs and wellness centers are emerging as important contributors to patient support and education .

Oman Celiac Disease Treatment Market Competitive Landscape

The Oman Celiac Disease Treatment Market is characterized by a dynamic mix of regional and international players. Leading participants such as Muscat Pharmacy & Stores LLC, Oman Pharmaceutical Products Co. LLC, Sultan Qaboos University Hospital, Aster DM Healthcare, NMC Healthcare, Al Shifa Pharmacy, Al Jazeera Healthcare Group, Gulf Gluten-Free Foods LLC, Oman Celiac Disease Association, Muscat Private Hospital, Al Batinah Hospital, Oman Medical Specialty Board, Al Noor Hospital, Nutri Free Oman, Dr. Nutrition Center Oman contribute to innovation, geographic expansion, and service delivery in this space.

Oman Celiac Disease Treatment Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Celiac Disease:The prevalence of Celiac disease in Oman is estimated to be around 1 in 100 individuals, translating to approximately 40,000 people affected. This rising incidence is attributed to genetic factors and dietary changes. The World Health Organization (WHO) indicates that the Middle East has seen a 20% increase in diagnosed cases over the past decade, driving demand for effective treatment options and gluten-free products in the region.
• Rising Awareness About Gluten-Free Diets:Awareness campaigns have significantly increased public knowledge about Celiac disease and the importance of gluten-free diets. In Oman, health organizations reported a 30% rise in inquiries about gluten-free products from the previous year to the current year. This growing awareness is supported by educational initiatives, leading to a higher demand for gluten-free food options and specialized treatments, thereby boosting market growth.
• Growth in Healthcare Infrastructure:Oman has invested heavily in healthcare infrastructure, with government spending reaching OMR 1.5 billion in future. This investment has led to improved diagnostic facilities and treatment options for Celiac disease. Enhanced healthcare access is crucial for early diagnosis and management, which is expected to increase the number of patients seeking treatment and gluten-free products, further propelling market growth.

Market Challenges

• Limited Availability of Gluten-Free Products:Despite rising demand, the availability of gluten-free products in Oman remains limited. Currently, only 15% of supermarkets stock a variety of gluten-free items, which restricts access for patients. This scarcity is compounded by the reliance on imports, which can lead to supply chain disruptions, ultimately hindering the growth of the Celiac disease treatment market in the region.
• High Cost of Specialized Treatments:The cost of specialized treatments for Celiac disease can be prohibitive, with average treatment expenses reaching OMR 1,200 annually per patient. This financial burden limits access for many individuals, particularly in lower-income brackets. The high costs associated with gluten-free diets and medical consultations pose significant barriers to effective disease management, impacting overall market growth.

Oman Celiac Disease Treatment Market Future Outlook

The future of the Oman Celiac disease treatment market appears promising, driven by increasing healthcare investments and a growing focus on patient education. As the prevalence of Celiac disease continues to rise, healthcare providers are likely to enhance diagnostic capabilities and treatment options. Additionally, the expansion of gluten-free product lines and the integration of health technology solutions will further support market growth, ensuring better management of the disease and improved patient outcomes.

Market Opportunities

• Expansion of Gluten-Free Product Lines:There is a significant opportunity for local manufacturers to expand gluten-free product lines. With a growing consumer base, companies can tap into this market by introducing diverse gluten-free options, potentially increasing market share and meeting the rising demand for healthier food alternatives.
• Collaborations with Healthcare Providers:Collaborating with healthcare providers presents a unique opportunity to enhance patient education and access to treatments. By partnering with hospitals and clinics, companies can facilitate better awareness and distribution of gluten-free products, ultimately improving patient management and treatment adherence in the region.